Patient Pathfinder: Clinical Trials
Clinical Trials for Hypertrophic Cardiomyopathy
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 29 active Hypertrophic Cardiomyopathy trials
A Long-Term Safety Extension Study of Mavacamten in Adults Who Have Completed MAVERICK-HCM or EXPLORER-HCM
Study Type: Interventional Phase 2
Pediatric Cardiomyopathy Mutation Analysis
Study Type: Observational
Natural History Study in Pediatric Patients With MYBPC3 Mutation-associated Cardiomyopathy
Study Type: Observational
Study of Pregnancy And Neonatal Health (SPAN)
Study Type: Interventional
A Prospective Incident Study of Arrhythmias in Hypertrophic Cardiomyopathy
Study Type: Observational
A Noninterventional, Single-Center Feasibility Study to Evaluate Measures of Heart Failure Risk
Study Type: Observational
Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers
Study Type: Observational
There are 29 active Hypertrophic Cardiomyopathy trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now